TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518.

James C Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.